SMO and melanoma: We also tested the effects of the combination of ERK5 (XMD8-92) or MEK5 (BIX02189) inhibitors with GLI (GANT61) or SMO (MRT-92) inhibitors on the viability of melanoma cells, used at low (IC10) concentrations.